Publikacijos:

  1. Bendix E. The papyrus Ebers: The Greatest Egyptian Medical Document. Copenhagen: Levin & Munksgaard, 1937, 135 p.
  2. Potter P. Hippocrates. Volume IX. England: Harvard University Press, 2010, 347 p.
  3. Totelin L. Hippocratic Recipes: Oral and Written Transmission of Pharmacological Knowledge in Fifth- and Fourth-Century Greece (Studies in Ancient Medicine). Leiden: Koninklijke Brill NV, 2008, 125 p.
  4. Adams F. The Genuine Works of Hippocrates: Translated from the Greek, with a Preliminary Discourse and Annotations. Volume II. London, printed for the Sydenham society,1849, 800-806 p. Prieiga internetu: https://babel.hathitrust.org/cgi/pt?id=nyp.33433011418963;view=1up;seq=15
  5. Sellar W., Watt M. Frankincense and Myrrh: Through the Ages and a Complete Guide to Their Use in Herbalism and Aromatherapy Today. Treatment for Wounds. Great Britain: C. W. Daniel Co. Lt, 1996, 128 p.
  6. Ammon P. Boswellic Acids in Chronic Inflammatory Diseases. Planta Medica. 2006; 72(12):1100-1116
  7. Krauss CA, Einfluss von Acetyl-alpha Boswelliasäure auf die proinflammatorische Aktivierunng von humanen, peripheren Monozyten: Ein Vergleich mit Dexamethason. Prieiga internetu [2003 12 11]: https://oparu.uniulm.de/xmlui/bitstream/handle/123456789/236/vts_3482.pdf?sequence=1&isAllowed=y
  8. Glaser T, Winter S, Groscurth P et al. Boswellic Acids and Malignant Glioma: Induction of Apoptosis but No Modulation of Drug Sensitivity. Prieiga internetu [1999 05]: https://europepmc.org/articles/PMC2362292
  9. Ammon HP. Boswellic acids (components of frankincense) as the active principle in treatment of chronic inflammatory diseases. Wien Med Wochenschr. 2002;152(15-16):373-8
  10. Ammon HP. Modulation of the immune system by Boswellia serrata extracts and boswellic acids. Phytomedicine. 2010;17(11):862-7
  11. Siemoneit U, Koeberle A, Rossi A et al. Inhibition of microsomal prostaglandin E2 synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincense. British Journal of Pharmacology. 2011;162(1):147-62.
  12. Hoernlein RF, Orlikowsky TH, Zehrer C. et al. Acetyl-11-keto-beta-boswellic acid induces apoptosis in HL-60 and CCRF-CEM cells and inhibits topoisomerase I. The Journal of Pharmacology and Experimental Therapeutics. 1999;288(2):613-9
  13. Safayhi H, Sailer ER, Ammon HP et al. Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-beta-boswellic acid. Molecular Pharmacology. 1995;47(6):1212-6.
  14. Sailer ER, Subramanian LR, Rall B et al. Acetyl-11-keto-beta-boswellic acid (AKBA): structure requirements for binding and 5-lipoxygenase inhibitory activity. British Journal of Pharmacology. 1996;117(4):615-8
  15. Ammon HP, Safayhi H, Mack T et al. Mechanism of antiinflammatory actions of curcumine and boswellic acids. Journal of Ethnopharmacology. 1993;38(2-3):113-9
  16. Safayhi H, Rall B, Sailer ER et al. Inhibition by boswellic acids of human leukocyte elastase. The Journal of Pharmacology and Experimental Therapeutics. 1997;281(1):460-3
  17. Safayhi H, Mack T, Sabieraj J et al. Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase. The Journal of Pharmacology and Experimental Therapeutics. 1992;261(3):1143-6
  18. Poeckel D, Tausch L, George S et al. 3-O-acetyl-11-keto-boswellic acid decreases basal intracellular Ca2+ levels and inhibits agonist-induced Ca2+ mobilization and mitogen-activated protein kinase activation in human monocytic cells. The Journal of Pharmacology and Experimental Therapeutics. 2006;316(1):224-32
  19. Henkel A, Kather N, Monch B et al. Boswellic acids from frankincense inhibit lipopolysaccharide functionality through direct molecular interference. Biochemical Pharmacology. 2012;83(1):115-21
  20. Nicole K. Dissertation. Synthese und Struktur-Wirkungs-Beziehungen von Boswelliasäuren und deren Derivaten. Prieiga internetu [2007]: https://publikationen.sulb.uni-saarland.de/handle/20.500.11880/22471
  21. Boden S, Bertsche Th, Schweiser S et al. Stimulation of Leukotriene Synthesis in Intact Polymorphonuclear Cells by the 5-Lipoxygenase Inhibitor 3-oxo-Tirucallic Acid. Molecular Pharmacology. 2001;60(2):267-73
  22. Krieglstein CF, Anthoni C, Rijcken EJ, et al. Acetyl-11-keto-beta-boswellic acid, a constituent of a herbal medicine from Boswellia serrata resin, attenuates experimental ileitis. Prieiga internetu [2001 04 16]: http://www.ncbi.nlm.nih.gov/pubmed/11355324
  23. Moussaieff A, Mechoulam R et al. Boswellia resin: from religious ceremonies to medical uses; a review of in-vitro, in-vivo and clinical trials. Journal of Pharmacy and Pharmacology. 2009;61(10):1281-93
  24. Moussaieff A, Shohami E, Kashman Y et al. Incensole acetate, a novel anti-inflammatory compound isolated from Boswellia resin, inhibits nuclear factor-kappa B activation. Molecular Pharmacology. 2007;72(6):1657-64.  
  25. Syrovets T, Büchele B, Krauss C, et al. Acetyl-Boswellic Acids Inhibit Lipopolysaccharide-Mediated TNF-α Induction in Monocytes by Direct Interaction with IκB Kinases. Prieiga internetu [2005 01 01]: https://www.jimmunol.org/content/174/1/498
  26. Moussaieff A, Yu J, Zhu H et al. Protective effects of incensole acetate on cerebral ischemic injury. Brain Research. 2012;1443:89-97
  27. Stürner KH, Stellmann JP, Dörr J et al. A Standardised Frankincense Extract Reduces Disease Activity in Relapsing-Remitting Multiple Sclerosis (the SABA Phase IIa Trial). Prieiga internetu [2017 12 16]: https://www.ncbi.nlm.nih.gov/pubmed/29248894
  28. Cuaz-Pérolin C, Billiet L, Baugé E et al. Antiinflammatory and Antiatherogenic Effects of the NF-KappaB Inhibitor Acetyl-11-Keto-Beta-Boswellic Acid in LPS-Challenged ApoE-/- Mice. Journal of Arteriosclerosis, Thrombosis, and Vascular Biology, 2007 28:272-277
  29. Sedighi B, Pardakhty A, Kamali H, et al. Effect of Boswellia papyrifera on cognitive impairment in multiple sclerosis. Iran Journal of Neurology 2014;13(3):149-153
  30. Sterk V, Büchele B, Simmet T. Effect of food intake on the bioavailability of boswellic acids from a herbal preparation in healthy volunteers. Planta Medica. 2004;70(12):1155-1160
  31. Seitz S. Dissertation: Naturwissenschaftliche-technische Fakultät III, Chemie, Pharmazie, Bio-und Wekstoffwissenschaft der Universität des Saarlandes. Isolierung und Strukturaufklärung von entzündungshemmenden Inhaltsstoffen aus Weihrauch. Prieiga internetu [2008 11 21] http://scidok.sulb.uni-saarland.de/volltexte/2008/1777/
  32. Kirste S, Treier M, Wehrle S, et al. Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors. Cancer, 2011;117(16):3788-3795
  33. Winking M, Sarikaya S, Rahmanian A, et al. Boswellic acids inhibit glioma growth: a new treatment option? Prieiga internetu [2000 02]: https://www.ncbi.nlm.nih.gov/pubmed/10894362.
  34. Xia L, Chen D, Han R, et al. Boswellic acid acetate induces apoptosis through caspase-mediated pathways in myeloid leukemia cells. Prieiga internetu [2005 03]: https://www.ncbi.nlm.nih.gov/pubmed/15767547.
  35. Yuan HQ, Kong F, Wang XL, et al. Inhibitory effect of acetyl-11-keto-beta-boswellic acid on androgen receptor by interference of Sp1 binding activity in prostate cancer cells. Prieiga internetu [2008 03 15]: https://www.ncbi.nlm.nih.gov/pubmed/18430409.
  36. Zhao W, Entschladen F, Liu H, et al. Boswellic Acid Acetate Induces Differentiation and Apoptosis in Highly Metastatic Melanoma and Fibrosarcoma Cells. Prieiga internetu [2003 01 29]: https://www.sciencedirect.com/science/article/pii/S0361090X02001708
  37. Sengupta K, Alluri KV, Satish AR, et al. A Double Blind, Randomized, Placebo Controlled Study of the Efficacy and Safety of 5-Loxin for Treatment of Osteoarthritis of the Knee.  Prieiga internetu [2008 07 30]: https://www.ncbi.nlm.nih.gov/pubmed/18667054. 
  38. Kimmatkar N, Thawani V, Hingorani L, et al. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee – a randomized double blind placebo controlled trial. Prieiga internetu [2003 01 10]: https://www.ncbi.nlm.nih.gov/pubmed/12622457
  39. Sontakke S, Thawani V, Pimpalkhute S, et al. Open, randomized, controlled clinical trial of Boswellia serrata extract as compared to valdecoxib in osteoarthritis of knee. Indian Journal of Pharmacology 2007;39: 27-29
  40. Gerhardt H, Seifert F, Buvari P, et al. Therapy of active Crohn’s disease with Boswellia serrata extract H15. Zeitschrift für Gastroenterol. 2001;39:11–17
  41. Gupta I, Parihar A, Malhotra P, et al. Effects of gum resin of Boswellia serrata in patients with chronic colitis. Planta Medica. 2001;67(5):391-395
  42. Madisch A, Miehlke S, Eichele O, et al. Boswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebo-controlled, multicenter trial. International Journal of Colorectal Disease. 2007;22:1445-1451
  43. Anthoni C, Laukoetter MG, Rijcken E, et al. Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis. Prieiga internetu [2006 01 19]: https://www.ncbi.nlm.nih.gov/pubmed/16423918
  44. Gupta I, Gupta V, Parihar A, et al. Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study. European Journal of Medical Research. 1998;3(11):511-514
  45. Singh SK, Bhusari S, Singh R, et al. Effect of acetyl 11-keto beta-boswellic acid on metastatic growth factor responsible for angiogenesis. Prieiga internetu [2006 11 10]: https://www.ncbi.nlm.nih.gov/pubmed/17257903
  46. Singh S, Khajuria A, Taneja SC,et al. Boswellic Acids and Glucosamine Show Synergistic Effect in Preclinical Anti-Inflammatory Study in Rats. Prieiga internetu [2007 07 01]: https://www.ncbi.nlm.nih.gov/pubmed/17481895
  47. Singh S, Khajuria A, Taneja SC, et al. The gastric ulcer protective effect of boswellic acids, a leukotriene inhibitor from Boswellia serrata, in rats. Prieiga internetu [2008 04 18]: https://www.ncbi.nlm.nih.gov/pubmed/18424019
  48. Henning Gerhardt. Boswellia serrata – eine Kortison-Ersatz-Therapie? Prieiga internetu: https://magendarm-zentrum.de/images/dokumente/formulare/sonstiges/therapie-mit-weihrauch.pdf.
  49. Gerhardt H, Seifert F, Buvari P, et al. Morbus Crohn: Weihrauch Besser Als Mesalazin? Prieiga internetu [2015 08 12]: https://www.deutsche-apotheker-zeitung.de/daz-az/2001/daz-12-2001/uid-428
  50. Weckesser S, Engel K, Simon-Haarhaus B, et al. Screening of Plant Extracts for Antimicrobial Activity against Bacteria and Yeasts with Dermatological Relevance. Prieiga internetu [2007 02 08]: https://www.sciencedirect.com/science/article/pii/S0944711306002303
  51. Glaser T, Winter S, Groscurth P et al. Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity. British journal of Cancer. 1999;80:756-65
  52. Talley JJ, Brown DL, Carter JS et al. 4-[5-Methyl-3-phenylisoxazol-4-yl]-benzenesulfonamide, Valdecoxib: A Potent and Selective Inhibitor of COX-2. J. Med. Chem. 2000;43:775-777